Neumeyer JL[au] - Search Results

Year	Number of Results
1962	1
1964	2
1966	1
1967	1
1968	1
1969	2
1970	3
1971	1
1973	2
1974	2
1975	4
1976	7
1977	6
1978	1
1979	1
1980	6
1981	2
1982	5
1983	9
1984	6
1985	8
1986	6
1987	1
1988	10
1989	4
1990	9
1991	7
1992	4
1993	7
1994	9
1995	7
1996	5
1997	3
1998	2
1999	3
2000	3
2001	2
2003	4
2004	6
2005	4
2006	4
2007	11
2008	6
2009	4
2010	6
2011	4
2012	2
2013	2
2014	4
2018	2
2019	1
2020	1
2021	1
2022	0

1

Kappa receptor bivalent ligands.

Peng X, Neumeyer JL. Peng X, et al. Among authors: neumeyer jl. Curr Top Med Chem. 2007;7(4):363-73. doi: 10.2174/156802607779941251. Curr Top Med Chem. 2007. PMID: 17305578 Review.

2

Advances in development of dopaminergic aporphinoids.

Zhang A, Zhang Y, Branfman AR, Baldessarini RJ, Neumeyer JL. Zhang A, et al. Among authors: neumeyer jl. J Med Chem. 2007 Jan 25;50(2):171-81. doi: 10.1021/jm060959i. J Med Chem. 2007. PMID: 17228858 Review. No abstract available.

3

Chemistry and pharmacology of marijuana.

Neumeyer JL, Shagoury RA. Neumeyer JL, et al. J Pharm Sci. 1971 Oct;60(10):1433-57. doi: 10.1002/jps.2600601002. J Pharm Sci. 1971. PMID: 4942969 Review. No abstract available.

4

Convenient synthesis of 18F-radiolabeled R-(-)-N-n-propyl-2-(3-fluoropropanoxy-11-hydroxynoraporphine.

Sromek AW, Zhang S, Akurathi V, Packard AB, Li W, Alagille D, Morley TJ, Baldwin R, Tamagnan G, Neumeyer JL. Sromek AW, et al. Among authors: neumeyer jl. J Labelled Comp Radiopharm. 2014 Dec;57(14):725-9. doi: 10.1002/jlcr.3246. Epub 2014 Nov 17. J Labelled Comp Radiopharm. 2014. PMID: 25400260 Free PMC article.

5

Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.

Ye N, Neumeyer JL, Baldessarini RJ, Zhen X, Zhang A. Ye N, et al. Among authors: neumeyer jl. Chem Rev. 2013 May 8;113(5):PR123-78. doi: 10.1021/cr300113a. Epub 2013 Mar 7. Chem Rev. 2013. PMID: 23464812 Review. No abstract available.

6

Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.

Zhang A, Neumeyer JL, Baldessarini RJ. Zhang A, et al. Among authors: neumeyer jl. Chem Rev. 2007 Jan;107(1):274-302. doi: 10.1021/cr050263h. Chem Rev. 2007. PMID: 17212477 Review. No abstract available.

7

Preliminary pharmacological evaluation of enantiomeric morphinans.

Sromek AW, Provencher BA, Russell S, Chartoff E, Knapp BI, Bidlack JM, Neumeyer JL. Sromek AW, et al. Among authors: neumeyer jl. ACS Chem Neurosci. 2014 Feb 19;5(2):93-9. doi: 10.1021/cn400205z. Epub 2014 Jan 8. ACS Chem Neurosci. 2014. PMID: 24393077 Free PMC article.

8

A non-anhydrous, minimally basic protocol for the simplification of nucleophilic ¹⁸F-fluorination chemistry.

Inkster JAH, Akurathi V, Sromek AW, Chen Y, Neumeyer JL, Packard AB. Inkster JAH, et al. Among authors: neumeyer jl. Sci Rep. 2020 Apr 22;10(1):6818. doi: 10.1038/s41598-020-61845-y. Sci Rep. 2020. PMID: 32321927 Free PMC article.

9

Letter: Vive la difference.

Neumeyer JL. Neumeyer JL. J Pharm Sci. 1976 Jun;65(6):IV. J Pharm Sci. 1976. PMID: 778375 Review. No abstract available.

10

Identification of fluorinated (R)-(-)-aporphine derivatives as potent and selective ligands at serotonin 5-HT_2C receptor.

Xu Y, Sromek AW, Neumeyer JL. Xu Y, et al. Among authors: neumeyer jl. Bioorg Med Chem Lett. 2019 Jan 15;29(2):230-233. doi: 10.1016/j.bmcl.2018.11.050. Epub 2018 Nov 23. Bioorg Med Chem Lett. 2019. PMID: 30545651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results